Recovery following prolonged gram-negative shock and "shock lung".
D001002:Anuria / Q000209:etiology; D001795:Blood Pressure Determination; D002512:Cephalothin / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D003911:Dextrans / Q000627:therapeutic use; D004927:Escherichia coli Infections / Q000150:complications*; D006801:Humans; D007263:Infusions, Parenteral; D007601:Jugular Veins; D007612:Kanamycin / Q000627:therapeutic use; D008168:Lung / Q000000981:diagnostic imaging; D008171:Lung Diseases / Q000150:complications*; D008297:Male; D008875:Middle Aged; D013902:Radiography, Thoracic; D012131:Respiratory Insufficiency / Q000209:etiology; D018805:Sepsis / Q000150:complications; D012772:Shock, Septic / Q000150:complications*; D014547:Urinary Diversion
D003911:Dextrans; D007612:Kanamycin; D003907:Dexamethasone; D002512:Cephalothin